Cenerimod
ID-064A301
Phase 3 small_molecule active
Quick answer
Cenerimod for Lupus Erythematosus, Systemic is a Phase 3 program (small_molecule) at Viatris Pharmaceuticals Co., with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Viatris Pharmaceuticals Co.,
- Indication
- Lupus Erythematosus, Systemic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active